Clinical Trials Logo

Clinical Trial Summary

This is a prospective, multicenter, randomized, controlled investigation. Subjects in which bleeding from the exposed parenchymal surface is observed intraoperatively following the ligature of vessels visible with the unaided eye will be randomized to an adjunctive application of BioFoam or a standard topical hemostatic agent (Gelfoam with thrombin, in the form of Gelfoam Plus) to the entire exposed parenchymal surface. Following primary treatment of the exposed parenchymal surface as prescribed by the randomization scheme, treatment sites will be visually evaluated for the continued presence of bleeding. The overall objective of this investigation is to collect clinical data concerning the safety and effectiveness of BioFoam used as an adjunct to conservative measures of achieving hemostasis, such as manual pressure, cautery, and ligation, for intraoperative capillary, arteriolar, and venular bleeding (5 second stack of 5 gauze surface "Bleeding Score" = 1b or 2, score to be validated) on newly resected liver parenchyma in hemodynamically stable (American College of Surgeons' Advanced Trauma Life Support Class I Hemorrhage) and non-coagulopathic patients in the open treatment of exposed liver parenchyma versus a standard topical hemostatic agent, Gelfoam Plus. It is not intended for traumatic liver injury. The investigation will be conducted at a maximum of three investigational sites.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01458561
Study type Interventional
Source CryoLife, Inc.
Contact
Status Terminated
Phase Phase 3
Start date October 2010
Completion date September 2012

See also
  Status Clinical Trial Phase
Recruiting NCT05900037 - GATT-Patch Versus SURGICEL® Original in Minimally Invasive Liver and Gallbladder Surgery N/A
Recruiting NCT04609410 - Bleeding in Laparoscopic Liver Surgery N/A
Completed NCT01656759 - Use of a Novel Fibrin Sealant in Total Knee Arthroplasty Phase 2/Phase 3
Completed NCT01651806 - Weighted Versus Uniform Dose of Tranexamic Acid in Patients Undergoing Primary, Knee Arthroplasty Phase 2/Phase 3
Completed NCT05867342 - Effects of Adrenaline Infiltration on Surgical Field of View in Endoscopic Sinus Surgery Phase 4
Not yet recruiting NCT05841251 - Phenylephrine Versus Tranexamic Acid to Control Bleeding in Patients Undergoing Inferior Turbinoplasty by Coblation N/A
Not yet recruiting NCT06450834 - Ostene in Thoracolumbar Decompression and Fusion Evaluated With VIBE
Not yet recruiting NCT06427707 - The Effect of Adding Either Propofol or Ketamine to Magnesium and Lidocaine Infusions in Nasal Surgeries. Phase 2/Phase 3
Active, not recruiting NCT01539057 - The Efficacy of the Administration of Fibrinogen in Liver Transplantation Phase 3
Completed NCT03820206 - The Value of Tranxemic Acid to Reduce Intraoperative Blood Loss During Elective Cesarean Sections in High Risk Women N/A
Completed NCT01891461 - Study to Compare the Addition of Floseal to Our Standard of Care to Control Post Operative Bleeding in TKR Phase 4
Completed NCT03047070 - Lidocaine in ERAS for FESS Phase 2
Completed NCT04188184 - Tranexamic Acid Versus Epinephrine During Exploratory Tympanotomy N/A
Recruiting NCT04697498 - Bilateral Bi-level Erector Spine Plane Block as a Component of General Anesthesia in Surgical Correction of Spinal Deformations N/A
Completed NCT05385952 - GATT-Patch Versus TachoSil in Liver Surgery N/A
Completed NCT02229292 - Prevention of Intraoperative Bleeding and Postoperative Swelling in Orthognathic Surgery Through the Use of Tranexamic Acid Phase 4
Not yet recruiting NCT06264596 - Epinephrine in Irrigation Fluid for Visualization During Ankle Surgery Phase 3
Recruiting NCT03112135 - Effect of Topical and Systemic Tranexemic Acid on Bleeding During Ear Exploration Surgery Phase 2
Recruiting NCT06399445 - Measurement of Blood Loss in Adenotonsillectomy During General Anesthesia According to the Application of Nondepolarizing Muscle Relaxants Phase 4